These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23316991)

  • 21. [New fast-acting insulin analog. This insulin profits type l and type 2 diabetics].
    Wepner U
    MMW Fortschr Med; 2004 Nov; 146(47):62-3. PubMed ID: 15624662
    [No Abstract]   [Full Text] [Related]  

  • 22. Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes.
    Kreugel G; Keers JC; Kerstens MN; Wolffenbuttel BH
    Diabetes Technol Ther; 2011 Jul; 13(7):737-41. PubMed ID: 21476936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bolus calculator settings in well-controlled type 1 diabetes patients (glycated hemoglobin < 7%) treated with insulin pumps.
    Matejko B; Grzanka M; Kieć-Wilk B; Małecki MT; Klupa T
    J Diabetes Sci Technol; 2013 May; 7(3):800-1. PubMed ID: 23759415
    [No Abstract]   [Full Text] [Related]  

  • 24. [New concepts in blood glucose determination in insulin therapy].
    Kellerer M
    Krankenpfl J; 2005; 43(4-6):149. PubMed ID: 16171092
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment-induced neuropathy of diabetes related to abrupt glycemic control.
    Stainforth-Dubois M; McDonald EG
    CMAJ; 2021 Jul; 193(28):E1085-E1088. PubMed ID: 34281965
    [No Abstract]   [Full Text] [Related]  

  • 26. Age and A1C are important clinical predictors of continuous subcutaneous insulin infusion efficacy in type 1 diabetic patients.
    Lepore G; Dodesini AR; Nosari I; Trevisan R
    Diabetes Care; 2005 Jul; 28(7):1834-5. PubMed ID: 15983352
    [No Abstract]   [Full Text] [Related]  

  • 27. No effect of periodic continuous glucose monitoring on hemoglobin A1c in poorly regulated type 1 patients.
    Andersen HU; Kjelmann M; Wittrup M; Almdal TP
    J Diabetes Sci Technol; 2013 May; 7(3):802-3. PubMed ID: 23759416
    [No Abstract]   [Full Text] [Related]  

  • 28. Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes.
    Rosenstock J; Cappelleri JC; Bolinder B; Gerber RA
    Diabetes Care; 2004 Jun; 27(6):1318-23. PubMed ID: 15161782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Decision Support Software to Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year.
    Bode B; Clarke JG; Johnson J
    J Diabetes Sci Technol; 2018 Jan; 12(1):124-128. PubMed ID: 29251061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of baseline HbA1c and HbA1c reduction following insulin therapy in Type 2 diabetes.
    Giugliano D; Esposito K
    Diabet Med; 2011 Feb; 28(2):247. PubMed ID: 21219438
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypoglycemia--simply annoying or dangerous?].
    Kern W
    MMW Fortschr Med; 2016 Jun; 158(11):67-70. PubMed ID: 27271419
    [No Abstract]   [Full Text] [Related]  

  • 32. [Glycemic control and diabetic complications].
    Yamada Y
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():604-8. PubMed ID: 15999778
    [No Abstract]   [Full Text] [Related]  

  • 33. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical research observations with use of exubera in patients with type 1 and 2 diabetes.
    Cefalu WT; Wang ZQ
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S28-40. PubMed ID: 17563301
    [No Abstract]   [Full Text] [Related]  

  • 35. Glycemic Tracking Before and After Insulin Pump Initiation.
    Johnson A; Hill NE; Godsland I; Oliver NS
    J Diabetes Sci Technol; 2020 Sep; 14(5):970-971. PubMed ID: 32146846
    [No Abstract]   [Full Text] [Related]  

  • 36. 6(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, April 25-27, 2013, Riga, Latvia.
    Alzaid A; Schlaeger C; Hinzmann R
    Diabetes Technol Ther; 2013 Dec; 15(12):1033-52. PubMed ID: 24074038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diabetic complications: good metabolic control protects].
    MMW Fortschr Med; 2011 Apr; 153(15):44-5. PubMed ID: 21667560
    [No Abstract]   [Full Text] [Related]  

  • 38. Exubera inhaled insulin in patients with type 1 and type 2 diabetes: the first 12 months.
    Alabraba V; Farnsworth A; Leigh R; Dodson P; Gough SC; Smyth T
    Diabetes Technol Ther; 2009 Jul; 11(7):427-30. PubMed ID: 19580355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin therapy in children and adolescents.
    Tamborlane WV; Sikes KA
    Endocrinol Metab Clin North Am; 2012 Mar; 41(1):145-60. PubMed ID: 22575411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Taking the peak out of blood pressure. Diabetics can also live spontaneously].
    MMW Fortschr Med; 1999 Dec; 141(49-50):66-7. PubMed ID: 10726151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.